465 related articles for article (PubMed ID: 25456324)
1. Supervised injection services: what has been demonstrated? A systematic literature review.
Potier C; Laprévote V; Dubois-Arber F; Cottencin O; Rolland B
Drug Alcohol Depend; 2014 Dec; 145():48-68. PubMed ID: 25456324
[TBL] [Abstract][Full Text] [Related]
2. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T
PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391
[TBL] [Abstract][Full Text] [Related]
3. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
Notta D; Black B; Chu T; Joe R; Lysyshyn M
Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
[TBL] [Abstract][Full Text] [Related]
4. Risk environments facing potential users of a supervised injection site in Ottawa, Canada.
Shaw A; Lazarus L; Pantalone T; LeBlanc S; Lin D; Stanley D; Chepesiuk C; Patel S; Tyndall M;
Harm Reduct J; 2015 Oct; 12():49. PubMed ID: 26493319
[TBL] [Abstract][Full Text] [Related]
5. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia.
Harris RE; Richardson J; Frasso R; Anderson ED
Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143
[TBL] [Abstract][Full Text] [Related]
6. Use of on-site detoxification services co-located with a supervised injection facility.
Gaddis A; Kennedy MC; Nosova E; Milloy MJ; Hayashi K; Wood E; Kerr T
J Subst Abuse Treat; 2017 Nov; 82():1-6. PubMed ID: 29021106
[TBL] [Abstract][Full Text] [Related]
7. To what extent do supervised drug consumption services incorporate non-injection routes of administration? A systematic scoping review documenting existing facilities.
Speed KA; Gehring ND; Launier K; O'Brien D; Campbell S; Hyshka E
Harm Reduct J; 2020 Oct; 17(1):72. PubMed ID: 33028363
[TBL] [Abstract][Full Text] [Related]
8. Supervised Injection Facility Utilization Patterns: A Prospective Cohort Study in Vancouver, Canada.
Kennedy MC; Klassen DC; Dong H; Milloy MS; Hayashi K; Kerr TH
Am J Prev Med; 2019 Sep; 57(3):330-337. PubMed ID: 31377091
[TBL] [Abstract][Full Text] [Related]
9. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N
Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940
[TBL] [Abstract][Full Text] [Related]
10. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?
Salmon AM; Thein HH; Kimber J; Kaldor JM; Maher L
Int J Drug Policy; 2007 Jan; 18(1):46-53. PubMed ID: 17689343
[TBL] [Abstract][Full Text] [Related]
11. Substances injected at the Sydney supervised injecting facility: A chemical analysis of used injecting equipment and comparison with self-reported drug type.
Lefrancois E; Belackova V; Silins E; Latimer J; Jauncey M; Shimmon R; Mozaner Bordin D; Augsburger M; Esseiva P; Roux C; Morelato M
Drug Alcohol Depend; 2020 Apr; 209():107909. PubMed ID: 32145660
[TBL] [Abstract][Full Text] [Related]
12. Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States.
Davidson PJ; Lopez AM; Kral AH
Int J Drug Policy; 2018 Mar; 53():37-44. PubMed ID: 29278831
[TBL] [Abstract][Full Text] [Related]
13. Supervised Injection Facilities as Harm Reduction: A Systematic Review.
Levengood TW; Yoon GH; Davoust MJ; Ogden SN; Marshall BDL; Cahill SR; Bazzi AR
Am J Prev Med; 2021 Nov; 61(5):738-749. PubMed ID: 34218964
[TBL] [Abstract][Full Text] [Related]
14. An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation.
Krüsi A; Small W; Wood E; Kerr T
AIDS Care; 2009 May; 21(5):638-44. PubMed ID: 19444673
[TBL] [Abstract][Full Text] [Related]
15. Changes in public order after the opening of an overdose monitoring facility for people who inject drugs.
León C; Cardoso LJP; Johnston S; Mackin S; Bock B; Gaeta JM
Int J Drug Policy; 2018 Mar; 53():90-95. PubMed ID: 29294417
[TBL] [Abstract][Full Text] [Related]
16. Supervised injection facilities in Canada: past, present, and future.
Kerr T; Mitra S; Kennedy MC; McNeil R
Harm Reduct J; 2017 May; 14(1):28. PubMed ID: 28521829
[TBL] [Abstract][Full Text] [Related]
17. Potential use of supervised injection services among people who inject drugs in a remote and mid-size Canadian setting.
Mitra S; Rachlis B; Krysowaty B; Marshall Z; Olsen C; Rourke S; Kerr T
BMC Public Health; 2019 Mar; 19(1):284. PubMed ID: 30849946
[TBL] [Abstract][Full Text] [Related]
18. Take-home naloxone possession among people who inject drugs in rural West Virginia.
Allen ST; White RH; O'Rourke A; Grieb SM; Kilkenny ME; Sherman SG
Drug Alcohol Depend; 2019 Nov; 204():107581. PubMed ID: 31574407
[TBL] [Abstract][Full Text] [Related]
19. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
Kerr T; Small W; Moore D; Wood E
Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
[TBL] [Abstract][Full Text] [Related]
20. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study.
Kerr T; Stoltz JA; Tyndall M; Li K; Zhang R; Montaner J; Wood E
BMJ; 2006 Jan; 332(7535):220-2. PubMed ID: 16439401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
